Cargando…
Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China
OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747942/ https://www.ncbi.nlm.nih.gov/pubmed/36530668 http://dx.doi.org/10.3389/fpubh.2022.1018084 |
_version_ | 1784849716059570176 |
---|---|
author | Hao, Jingjing Yao, Qiang Lin, Yidie Sun, Yue Zhang, Baiyang Hu, Meijing Zhang, Jing Zhao, Ningxuan Pei, Jiao Liu, Zhonghua Zhu, Cairong |
author_facet | Hao, Jingjing Yao, Qiang Lin, Yidie Sun, Yue Zhang, Baiyang Hu, Meijing Zhang, Jing Zhao, Ningxuan Pei, Jiao Liu, Zhonghua Zhu, Cairong |
author_sort | Hao, Jingjing |
collection | PubMed |
description | OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A Markov microsimulation model was conducted from a social perspective, and the input parameters were obtained from published literature or publicly available data. Two screening strategies for pre-DM based on CDRS were built and compared with the control group to determine the cost-effective strategy. The screening strategy of the control group was screening for pre-DM by fasting plasma glucose (FPG) test in adults undergoing annual health examination and no screening in adults without an annual health examination (status quo). Two screening strategies were strategy 1: screening for pre-DM using CDRS in all adults (including with or without an annual health examination); and strategy 2: supplemental self-screening for pre-DM using CDRS in adults without an annual health examination, based on the status quo. We focus on the cumulative prevalence of T2DM and the incremental cost-effectiveness ratio which signifies the cost per case of T2DM prevented. We also evaluated the cost-effectiveness from the health system perspective. One-way and probabilistic sensitivity analyses were conducted to verify the robustness of the results. RESULTS: The costs a case of T2DM prevented for strategy 1 compared with the control group and strategy 2 were $299.67 (95% CI 298.88, 300.46) and $385.89 (95% CI 381.58, 390.20), respectively. In addition, compared with the control group, the cost of strategy 2 to prevent a case of T2DM was $272.23 (95% CI 271.50, 272.96). CONCLUSIONS: Screening for pre-DM using CDRS in all adults was the most cost-effective health policy. We suggest that medical institutions replace FPG with CDRS for pre-DM screening; at the same time, self-screening for pre-DM using CDRS is widely promoted among adults without an annual health examination. There were still some disputes about how CDRS is included in the health examination projects, so strategy 2 should be considered as an alternative screening strategy. Findings provide a reference for the application of the CDRS in pre-DM screening and contribute to T2DM prevention. |
format | Online Article Text |
id | pubmed-9747942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97479422022-12-15 Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China Hao, Jingjing Yao, Qiang Lin, Yidie Sun, Yue Zhang, Baiyang Hu, Meijing Zhang, Jing Zhao, Ningxuan Pei, Jiao Liu, Zhonghua Zhu, Cairong Front Public Health Public Health OBJECTIVE: Studies have shown that screening for pre-diabetes mellitus (pre-DM) is essential to prevent type 2 diabetes mellitus (T2DM). This study evaluates the cost-effectiveness of two screening strategies that apply the Chinese Diabetes Risk Score (CDRS) to screen for pre-DM in China. METHODS: A Markov microsimulation model was conducted from a social perspective, and the input parameters were obtained from published literature or publicly available data. Two screening strategies for pre-DM based on CDRS were built and compared with the control group to determine the cost-effective strategy. The screening strategy of the control group was screening for pre-DM by fasting plasma glucose (FPG) test in adults undergoing annual health examination and no screening in adults without an annual health examination (status quo). Two screening strategies were strategy 1: screening for pre-DM using CDRS in all adults (including with or without an annual health examination); and strategy 2: supplemental self-screening for pre-DM using CDRS in adults without an annual health examination, based on the status quo. We focus on the cumulative prevalence of T2DM and the incremental cost-effectiveness ratio which signifies the cost per case of T2DM prevented. We also evaluated the cost-effectiveness from the health system perspective. One-way and probabilistic sensitivity analyses were conducted to verify the robustness of the results. RESULTS: The costs a case of T2DM prevented for strategy 1 compared with the control group and strategy 2 were $299.67 (95% CI 298.88, 300.46) and $385.89 (95% CI 381.58, 390.20), respectively. In addition, compared with the control group, the cost of strategy 2 to prevent a case of T2DM was $272.23 (95% CI 271.50, 272.96). CONCLUSIONS: Screening for pre-DM using CDRS in all adults was the most cost-effective health policy. We suggest that medical institutions replace FPG with CDRS for pre-DM screening; at the same time, self-screening for pre-DM using CDRS is widely promoted among adults without an annual health examination. There were still some disputes about how CDRS is included in the health examination projects, so strategy 2 should be considered as an alternative screening strategy. Findings provide a reference for the application of the CDRS in pre-DM screening and contribute to T2DM prevention. Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9747942/ /pubmed/36530668 http://dx.doi.org/10.3389/fpubh.2022.1018084 Text en Copyright © 2022 Hao, Yao, Lin, Sun, Zhang, Hu, Zhang, Zhao, Pei, Liu and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Hao, Jingjing Yao, Qiang Lin, Yidie Sun, Yue Zhang, Baiyang Hu, Meijing Zhang, Jing Zhao, Ningxuan Pei, Jiao Liu, Zhonghua Zhu, Cairong Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title | Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title_full | Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title_fullStr | Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title_full_unstemmed | Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title_short | Cost-effectiveness of two screening strategies based on Chinese diabetes risk score for pre-diabetes in China |
title_sort | cost-effectiveness of two screening strategies based on chinese diabetes risk score for pre-diabetes in china |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747942/ https://www.ncbi.nlm.nih.gov/pubmed/36530668 http://dx.doi.org/10.3389/fpubh.2022.1018084 |
work_keys_str_mv | AT haojingjing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT yaoqiang costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT linyidie costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT sunyue costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT zhangbaiyang costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT humeijing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT zhangjing costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT zhaoningxuan costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT peijiao costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT liuzhonghua costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina AT zhucairong costeffectivenessoftwoscreeningstrategiesbasedonchinesediabetesriskscoreforprediabetesinchina |